19 January 2026
: Case report
Diagnosis of Dual c- and p-ANCA Vasculitis Following SARS-CoV-2 Infection: A Case Report
Rare disease
Isaac B. WolfkindDOI: 10.12659/AJCR.950958
Am J Case Rep 2026; 27:e950958
Figure 1 Timeline of the patient’s disease progression from her second SARS-CoV-2 infection in August 2023 through her diagnosis and treatment of dual c- and p-ANCA vasculitis. Key events include progressive sinopulmonary symptoms, iron-deficiency anemia, acute renal failure, diagnosis of c- and p-ANCA granulomatosis with polyangiitis, initial treatment with plasmapheresis, steroids, and rituximab, and stabilization with prednisone, avacopan, and dialysis.






